Welichem commences enrollment in WBI-1001 Phase IIa clinical trial for psoriasis

Download PDF Copy

Feb 24 2010

NewsGuard 100/100 Score

Welichem announced that the Company has begun to enroll patients in a Phase IIa clinical trial with its lead candidate, WBI-1001. The Phase IIa clinical trial is a 12-Week, double-blinded, placebo-controlled study. The objectives of the trial are to evaluate the efficacy of the WBI-1001 cream in comparison to the vehicle and also to evaluate the safety and tolerability of the cream in patients with psoriasis.

It is planned that 60 patients (20 placebo and 40 active treatment) will be enrolled in the trial that is anticipated to be concluded in 7 to 9 months.

Source: WELICHEM BIOTECH INC.

Posted in: Drug Trial News | Disease/Infection News

Tags: Cancer, Clinical Trial, Efficacy, Placebo, Psoriasis

Comments (0)

Download PDF Copy

Suggested Reading

Cognitive behavioral therapy shows promise for prolonged grief disorder

Cognitive behavioral therapy shows promise for prolonged grief disorder

Ozempic effective for patients with chronic kidney damage

Ozempic effective for patients with chronic kidney damage

Hormone hepcidin identified as potential trigger for psoriasis

Hormone hepcidin identified as potential trigger for psoriasis

Vitiligo linked to increased risk of heart disease and stroke, study finds

Vitiligo linked to increased risk of heart disease and stroke, study finds

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

HEPA air purifiers fall short in cutting respiratory infections in aged-care facilities

HEPA air purifiers fall short in cutting respiratory infections in aged-care facilities

Incorrect arm positioning inflates blood pressure readings, risking misdiagnosis

Incorrect arm positioning inflates blood pressure readings, risking misdiagnosis

At-home phototherapy proves effective for psoriasis treatment

At-home phototherapy proves effective for psoriasis treatment

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Weight loss drug semaglutide may offer relief for knee arthritis pain